Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCV13 and pneumococcal colonisation in Malawi
PACTR202008503507113Phase 3Completed
- Sponsor
- Liverpool School of Tropical Medicine
- Start
- Mar 2021
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3 trial of Prevnar 13 in pneumococcal disease (2 arms), sponsored by Liverpool School of Tropical Medicine. Started Mar 2021; status: completed.
02
Drugs
Prevnar 13
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on PACTR202008503507113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202008503507113.